4.4 Article

High-quality human preimplantation embryos actively influence endometrial stromal cell migration

Journal

JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
Volume 35, Issue 4, Pages 659-667

Publisher

SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10815-017-1107-z

Keywords

Implantation; Endometrium; Embryo; Cross-talk; Decidualization

Funding

  1. Amsterdam Reproduction and Development Institute of the Academic Medical Center
  2. VU University Medical Center

Ask authors/readers for more resources

The purpose of this paper is to study whether human preimplantation embryos regulate endometrial stromal cell (hESC) migration. Primary hESCs were isolated from fertile patients undergoing hysterectomy for benign conditions (uterine scar niche n = 3, dysmenorrhea n = 2; no hormonal treatment). Migration and proliferation assays were performed by culturing decidualized or non-decidualized hESCs in the presence of embryo conditioned medium (ECM) from high-quality embryos (fragmentation <= 20%) or from low-quality embryos (fragmentation > 20%) or in non-conditioned medium from the same dishes (control). ECM samples from 425 individually cultured human embryos were used in this study. ECM from high-quality embryos, i.e., with a low percentage of fragmentation, actively stimulated decidualized hESC migration (p < 0.001). This effect was consistent throughout embryonic development from cleavage stage embryos with 2-7 cells (high quality vs. control; p = 0.036), 8-18 cells (high quality vs. control; p < 0.001) to morulae (high quality vs. control; p = 0.003). Additionally, linear regression analysis showed that hESC migration was influenced by embryo quality (fragmentation, beta - 0.299; p = 0.025) and not developmental stage (cell number, beta 0.177; p = 0.176) or maternal age (beta - 0.036; p = 0.78). Opposite to decidualized hESCs, the migration response of non-decidualized hESCs was inhibited by ECM from high-quality embryos (p = 0.019). ECM from low-quality embryos, i.e., with a high percentage of fragmentation, did not cause an altered migration response in decidualized hESCs (p = 0.860) or non-decidualized hESCs (p = 0.986). Furthermore, ECM of both high- and low-quality human embryos did not influence the number of proliferating cells (p = 0.375) and the cell cycle time (p = 0.297) of non-decidualized or decidualized hESCs. This study reveals a mechanism by which high-quality human preimplantation embryos actively interact with the endometrium to increase their chances of successful implantation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Obstetrics & Gynecology

Not publishing important data from RCTs is no longer an option

M. Van Wely, K. Kirkegaard, C. De Geyter, C. B. Lambalk

HUMAN REPRODUCTION (2021)

Article Obstetrics & Gynecology

Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function

Anne-Lotte L. F. Van der Kooi, Marloes van Dijk, Linda Broer, Marleen H. van den Berg, Joop S. E. Laven, Flora E. van Leeuwen, Cornelis B. Lambalk, Annelies Overbeek, Jacqueline J. Loonen, Helena J. van der Pal, Wim J. Tissing, Birgitta Versluys, Dorine Bresters, Catharina C. M. Beerendonk, Cecile R. Ronckers, Margriet Van der Heiden-van der Loo, Gertjan L. Kaspers, Andrica C. H. de Vries, Leslie L. Robison, Melissa M. Hudson, Wassim Chemaitilly, Julianne Byrne, Claire Berger, Eva Clemens, Uta Dirksen, Jeanette Falck Winther, Sophie D. Fossa, Desiree Grabow, Riccardo Haupt, Melanie Kaiser, Tomas Kepak, Jarmila Kruseova, Dalit Modan-Moses, Saskia M. F. Pluijm, Claudia Spix, Oliver Zolk, Peter Kaatsch, Jesse H. Krijthe, Leontien C. Kremer, Yutaka Yasui, Russell J. Brooke, Andre G. Uitterlinden, Marry M. Van den Heuvel-Eibrink, Eline Van Dulmen-den Broeder

Summary: The study found that female childhood cancer survivors carrying a variant in the BRSK1 gene have an increased likelihood of reduced ovarian function after high-dose alkylating chemotherapy. Further research may help in providing personalized counseling regarding assisted reproductive technology and fertility preservation procedures.

HUMAN REPRODUCTION (2021)

Article Obstetrics & Gynecology

Bi-allelic variants in DNA mismatch repair proteins MutS Homolog MSH4 and MSH5 cause infertility in both sexes

M. J. Wyrwoll, E. S. van Walree, G. Hamer, N. Rotte, M. M. Motazacker, H. Meijers-Heijboer, M. Alders, A. Meissner, E. Kaminsky, M. Woeste, C. Krallmann, S. Kliesch, T. J. Hunt, A. T. Clark, S. Silber, B. Stallmeyer, C. Friedrich, A. M. M. van Pelt, I. B. Mathijssen, F. Tuettelmann

Summary: The study identified bi-allelic variants in MSH4 and MSH5 as causes of male infertility, expanding the understanding of genetic factors contributing to azoospermia.

HUMAN REPRODUCTION (2022)

Article Obstetrics & Gynecology

Economic evaluation of endometrial scratching before the second IVF/ICSI treatment: a cost-effectiveness analysis of a randomized controlled trial (SCRaTCH trial)

N. E. van Hoogenhuijze, R. van Eekelen, F. Mol, I Schipper, E. R. Groenewoud, M. A. F. Traas, C. A. H. Janssen, G. Teklenburg, J. P. de Bruin, R. H. F. van Oppenraaij, J. W. M. Maas, E. Moll, K. Fleischer, M. H. A. van Hooff, C. H. de Koning, A. E. P. Cantineau, C. B. Lambalk, M. Verberg, A. M. van Heusden, A. P. Manger, M. M. E. van Rumste, L. F. van der Voet, Q. D. Pieterse, J. Visser, E. A. Brinkhuis, J. E. den Hartog, M. W. Glas, N. F. Klijn, M. van der Zanden, M. L. Bandell, J. C. Boxmeer, J. van Disseldorp, J. Smeenk, M. van Wely, M. J. C. Eijkemans, H. L. Torrance, F. J. M. Broekmans

Summary: Endometrial scratch prior to the second fresh IVF/ICSI treatment may increase live birth rate, but comes with higher costs and uncertainty in effectiveness.

HUMAN REPRODUCTION (2022)

Editorial Material Obstetrics & Gynecology

Editor's Choice: Modelling chance of pregnancy in the general population

Cornelis (Nils) Lambalk

HUMAN REPRODUCTION (2022)

Article Obstetrics & Gynecology

Can hysterosalpingo-foam sonography replace hysterosalpingography as first-choice tubal patency test? A randomized non-inferiority trial

Nienke van Welie, Joukje van Rijswijk, Kim Dreyer, Machiel H. A. van Hooff, Jan Peter de Bruin, Harold R. Verhoeve, Femke Mol, Wilhelmina M. van Baal, Maaike A. F. Traas, Arno M. van Peperstraten, Arentje P. Manger, Judith Gianotten, Cornelia H. de Koning, Aafke M. H. Koning, Neriman Bayram, David P. van der Ham, Francisca P. J. M. Vrouenraets, Michaela Kalafusova, Bob I. G. van de Laar, Jeroen Kaijser, Arjon F. Lambeek, Wouter J. Meijer, Frank J. M. Broekmans, Olivier Valkenburg, Lucy F. van der Voet, Jeroen van Disseldorp, Marieke J. Lambers, Rachel Tros, Cornelis B. Lambalk, Jaap Stoker, Madelon van Wely, Patrick M. M. Bossuyt, Ben Willem J. Mol, Velja Mijatovic

Summary: HyFoSy and HSG produce similar findings in a majority of patients and clinical management based on the results of either HyFoSy or HSG leads to comparable pregnancy outcomes. HyFoSy is experienced as significantly less painful.

HUMAN REPRODUCTION (2022)

Article Public, Environmental & Occupational Health

Oil-based versus water-based contrast media for hysterosalpingography in infertile women of advanced age, with ovulation disorders or a high risk for tubal pathology: study protocol of a randomized controlled trial (H2Oil2 study)

K. Rosielle, D. Kamphuis, N. van Welie, I. Roest, A. Mozes, E. J. P. van Santbrink, T. van de Laar, A. B. Hooker, A. G. Huppelschoten, W. Li, M. Y. Bongers, J. Stoker, M. van Wely, C. Koks, C. B. Lambalk, A. Hemingway, B. W. J. Mol, K. Dreyer, V. Mijatovic

Summary: This study aims to compare the fertility-enhancing effect and cost-effectiveness of using oil-based contrast and water-based contrast during hysterosalpingography in women of advanced age, women with ovulatory disorders, and women with a high risk for tubal pathology.

BMC WOMENS HEALTH (2022)

Review Endocrinology & Metabolism

Spermatogonial Stem Cell-Based Therapies: Taking Preclinical Research to the Next Level

Iris Sanou, Jillis van Maaren, Jitske Eliveld, Qijing Lei, Andreas Meissner, Annemieke A. de Melker, Geert Hamer, Ans M. M. van Pelt, Callista L. Mulder

Summary: Fertility preservation through biobanking of testicular tissue is recommended for boys undergoing treatment before puberty. However, current fertility therapies using SSCs are still in preclinical phases. Further research and resolution of major issues are needed for optimal clinical implementation.

FRONTIERS IN ENDOCRINOLOGY (2022)

Article Obstetrics & Gynecology

Fertility preservation for women with breast cancer: a multicentre randomized controlled trial on various ovarian stimulation protocols

Eva M. E. Balkenende, Taghride Dahhan, Catharina C. M. Beerendonk, Kathrin Fleischer, Dominic Stoop, Annelies M. E. Bos, Cornelis B. Lambalk, Roel Schats, Jesper M. J. Smeenk, Leonie A. Louwe, Astrid E. P. Cantineau, Jan Peter de Bruin, Sabine C. Linn, Fulco van der Veen, Madelon van Wely, Mariette Goddijn

Summary: Alternative ovarian stimulation protocols with tamoxifen or letrozole did not affect the number of cumulus-oocyte complexes (COCs) retrieved at follicle aspiration in women with breast cancer.

HUMAN REPRODUCTION (2022)

Article Genetics & Heredity

Methylome-wide analysis of IVF neonates that underwent embryo culture in different media revealed no significant differences

Rebekka M. Koeck, Florence Busato, Jorg Tost, Dimitri Consten, Jannie Van Echten-Arends, Sebastiaan Mastenbroek, Yvonne Wurth, Sylvie Remy, Sabine Langie, Tim S. Nawrot, Michelle Plusquin, Rossella Alfano, Esmee M. Bijnens, Marij Gielen, Ron van Golde, John C. M. Dumoulin, Han Brunner, Aafke P. A. van Montfoort, Masoud Zamani Esteki

Summary: There were no significant methylation differences in the umbilical cord blood methylome between IVF neonates developed in different IVF culture media, suggesting that the use of different culture media may not affect the epigenetic profile of IVF newborns.

NPJ GENOMIC MEDICINE (2022)

Article Biochemistry & Molecular Biology

How germline genes promote malignancy in cancer cells

Jan Willem Bruggeman, Jan Koster, Ans M. M. van Pelt, Dave Speijer, Geert Hamer

Summary: This article proposes a hypothesis that activating the germline program promotes cancer cell malignancy. The four hallmark processes of the germline, including meiosis, epigenetic plasticity, migration, and metabolic plasticity, enable germ cells and cancer cells to have replicative immortality. Especially, meiotic genes are frequently expressed in cancer, suggesting their potential role in oncogenesis.

BIOESSAYS (2023)

Article Obstetrics & Gynecology

Expectant management versus IUI in unexplained subfertility and a poor pregnancy prognosis (EXIUI study): a randomized controlled trial

J. A. Wessel, M. H. Mochtar, D. E. Besselink, H. Betjes, J. P. de Bruin, A. E. P. Cantineau, E. R. Groenewoud, A. B. Hooker, C. B. Lambalk, J. Kwee, E. M. Kaaijk, L. A. Louwe, J. W. M. Maas, B. W. J. Mol, M. M. E. van Rumste, M. A. F. Traas, M. Goddijn, M. van Wely, F. Mol

Summary: In couples with unexplained subfertility and a poor prognosis for natural conception, expectant management (EM) for 6 months is inferior to IUI with ovarian stimulation (IUI-OS) in terms of live births.

HUMAN REPRODUCTION (2022)

Article Obstetrics & Gynecology

A short versus a long time interval between semen collection and intrauterine insemination: a randomized controlled clinical trial

C. H. Statema-Lohmeijer, R. Schats, B. Lissenberg-Witte, E. H. Kostelijk, C. B. Lambalk, C. G. Vergouw

Summary: Does a shorter interval between semen collection and IUI increase the chance of ongoing pregnancy? A long interval resulted in a significant improvement in cumulative ongoing pregnancies and a shorter time to pregnancy.

HUMAN REPRODUCTION (2023)

Article Obstetrics & Gynecology

The needs of subfertile couples continuing to attempt natural conception: in-depth interviews

Felicia Dreischor, Ellen T. M. Laan, Fleur Peeters, Karen Peeraer, Cornelis B. Lambalk, Mariette Goddijn, Inge M. Custers, Eline A. F. Dancet

Summary: Couples hope for fertility clinic staff to incorporate expectant management into the clinic trajectory, interact with both partners, and provide advice on common peer experiences, lifestyle management, distress, and sexual challenges.

HUMAN REPRODUCTION OPEN (2022)

Article Oncology

Fertility Preservation in Childhood, Adolescent, and Young Adult Cancer 1 Fertility preservation for female patients with childhood , adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group

Renee L. Mulder, Anna Font-Gonzalez, Melissa M. Hudson, Hanneke M. van Santen, Erik A. H. Loeffen, Karen C. Burns, Gwendolyn P. Quinn, Eline van Dulmen-den Broeder, Julianne Byrne, Riccardo Haupt, W. Hamish Wallace, Marry M. van den Heuvel-Eibrink, Antoinette Anazodo, Richard A. Anderson, Anke Barnbrock, Joern D. Beck, Annelies M. E. Bos, Isabelle Demeestere, Christian Denzer, Natascia Di Iorgi, Holly R. Hoefgen, Rejin Kebudi, Cornelis Lambalk, Thorsten Langer, Lillian R. Meacham, Kenny Rodriguez-Wallberg, Catharyn Stern, Eveline Stutz-Grunder, Wendy van Dorp, Margreet Veening, Saskia Veldkamp, Eline van der Meulen, Louis S. Constine, Lisa B. Kenney, Marianne D. van de Wetering, Leontien C. M. Kremer, Jennifer Levine, Wim J. E. Tissing

Summary: This study aims to develop clinical practice guidelines for fertility preservation in female patients diagnosed with childhood, adolescent, and young adult cancer at age 25 years or younger. By utilizing the Grading of Recommendations Assessment, Development and Evaluation methodology, transparent recommendations were formed to facilitate the care of high-risk female patients. Collaboration led to a comprehensive review of existing evidence, transparent reporting, and achievement of global interdisciplinary consensus.

LANCET ONCOLOGY (2021)

No Data Available